Core Viewpoint - The "Implementation Plan for High-Quality Development of Traditional Chinese Medicine Industry (2026-2030)" aims to establish a collaborative development system for the entire industry chain by 2030, enhancing the stable supply of key raw materials, improving digital and green transformation levels, achieving breakthroughs in key technologies, and significantly increasing collaborative innovation levels [3][14]. Group 1: Development Goals - The plan sets four main goals: improving development quality, enhancing collaborative systems, fostering innovative products, and achieving breakthroughs in digital and green transformation [4][15]. - Specific tasks include cultivating 60 high-standard raw material production bases and establishing five innovation centers for the traditional Chinese medicine industry [4][15]. - The plan aims to promote the approval of innovative traditional Chinese medicine drugs and develop 10 major new traditional Chinese medicine products [4][15]. Group 2: Specific Actions - The plan outlines 15 specific tasks focusing on actions such as improving raw material quality and supply, collaborative innovation, enhancing manufacturing capabilities, revitalizing the national medicine industry, promoting traditional Chinese medicine products, and nurturing outstanding enterprises [5][16]. - It emphasizes the establishment of high-standard raw material production bases and the development of intelligent circulation and storage management systems for traditional Chinese medicine materials [7][18]. Group 3: Innovation and Technology - The plan encourages the use of artificial intelligence and big data to enhance the research and development of traditional Chinese medicine, including the creation of knowledge graphs for classic formulas and experiences from renowned practitioners [9][20]. - It also supports the clinical trials of new traditional Chinese medicine drugs and aims to shorten the research and development cycle while reducing costs [9][20]. Group 4: Market and Brand Development - The plan includes initiatives to protect intellectual property rights for traditional brands and improve the production processes of existing traditional Chinese medicine products to enhance their clinical and market value [6][17]. - It encourages collaboration between traditional Chinese medicine enterprises and e-commerce platforms to provide efficient purchasing experiences for patients [6][17].

Core Viewpoint - The article discusses the "Implementation Plan for the High-Quality Development of Traditional Chinese Medicine Industry (2026-2030)" issued by the Ministry of Industry and Information Technology and other departments, outlining goals for the development of the traditional Chinese medicine (TCM) industry over the next five years, focusing on supply stability, innovation, and digital transformation [1][3]. Group 1: Development Goals - The plan sets four major goals for the TCM industry by 2030, including the establishment of a collaborative development system, enhanced supply capabilities of key TCM raw materials, significant improvements in digital and green levels, and breakthroughs in key technologies [1][3]. - Specific tasks include improving the quality of TCM production, enhancing the collaborative system across the supply chain, and promoting the continuous emergence of innovative TCM products [3][5]. Group 2: Specific Actions - The plan outlines 15 specific tasks across six action areas, including actions to ensure stable supply of raw materials, promote collaborative innovation, enhance manufacturing capabilities, and revitalize the national medicine industry [5][9]. - For TCM raw materials, the plan emphasizes the construction of high-standard production bases and the establishment of a smart circulation and storage management system to ensure stable supply [7][9]. Group 3: Innovation and Product Development - The plan aims to foster the development of innovative TCM products, including the approval of new TCM drugs and the cultivation of major TCM varieties [3][5]. - It encourages collaboration between TCM enterprises and e-commerce platforms to enhance patient access to TCM products and improve the clinical and market value of TCM [5][9]. Group 4: Quality and Standards - The plan includes actions to enhance the quality standards of TCM, such as the formulation of national standards for TCM decoction pieces and the establishment of a quality traceability system [8][9]. - It also highlights the importance of protecting intellectual property rights for traditional brands and improving production processes for existing TCM products [5][9].

智通财经获悉，2月5日，工信部等八部门联合印发《中药（核心股）工业高质量发展实施方案(2026— 2030年)》，从全产业链视角为中药工业未来五年发展划定"路线图"。《方案》围绕原料供应、创新能 力、制造水平等维度设定量化目标：到2030年培育60个高标准中药原料生产基地、建设5个中药工业守 正创新中心、新培育10个中成药大品种，推动一批医疗机构中药制剂转化为中药创新药，制修订10项中 药工业数智技术相关行业标准，发布20个数智化转型升级典型案例，建设20个智能工厂、培育10个绿色 工厂。 相关概念股： 中国中药（核心股）(00570)：中国中药汇集传统中药精髓，传承了自明代以来开创的"梁仲弘腊丸 馆"、"冯了性"、"同济堂"、"源吉林"等祖铺老号，拥有"冯了性"、"安宁"、"同济堂"3个中华老字 号，"仙灵"、"同济堂"、"仙灵骨葆"、"天江药业"、"德众"5个驰名商标。 同仁堂国药(03613)：同仁堂集团有望新增一家A股上市公司。嘉事堂近日公告称，2月2日，公司股东与 中国北京同仁堂(集团)有限责任公司签署股份转让协议，约定将光大实业、光大健康持有的公司股份以 14.6亿元转让给同仁堂集团。本次交易完成 ...

Key Points - The article discusses various important announcements and developments in the financial and regulatory landscape, including trading schedules, policy implementations, and corporate news [2][3][4][5][9][10][12][16]. Group 1: Trading and Regulatory Announcements - The Shanghai and Shenzhen stock exchanges announced the trading schedule for the 2026 Spring Festival, with a break from February 15 to February 23, 2026, and normal trading resuming on February 24, 2026 [2]. - The Ministry of Industry and Information Technology and eight other departments released a plan for the high-quality development of the traditional Chinese medicine industry from 2026 to 2030, aiming to cultivate leading enterprises and establish 60 high-standard raw material production bases [2]. - The National Internet Information Office and 11 other departments issued opinions to enhance digital services for inbound travelers, targeting significant improvements by 2027 and achieving international leading standards by 2030 [3]. - The Ministry of Finance, General Administration of Customs, and State Taxation Administration announced a "zero tariff" policy for imported goods purchased by residents of Hainan Free Trade Port, with an annual tax-free purchase limit of 10,000 RMB [3]. Group 2: Corporate News - Meituan plans to acquire 100% of Dingdong Maicai's China business for approximately $717 million [9]. - ST Cube's stock price has significantly deviated from its fundamentals, leading to a suspension for verification [10]. - Infineon announced price increases for certain products effective April 1 [12]. - Gotion High-Tech plans to raise no more than 5 billion RMB through a private placement for projects related to power batteries [16].

Market Data - As of February 5, the Shanghai Composite Index fell by 0.64% to 4075.92 points, the Sci-Tech Innovation 50 Index dropped by 1.44% to 1432.52 points, the Shenzhen Component Index decreased by 1.44% to 13952.71 points, and the ChiNext Index declined by 1.55% to 3260.28 points [1] - In the U.S. stock market, the Dow Jones Industrial Average fell by 592.58 points, closing at 48908.72 points, a decrease of 1.20%. The S&P 500 Index dropped by 84.32 points to 6798.4 points, down 1.23%, while the Nasdaq Composite Index fell by 363.99 points to 22540.59 points, a decline of 1.59% [1] - International oil prices decreased on February 5, with light crude oil futures for March delivery falling by $1.85 to $63.29 per barrel, a drop of 2.84%. Brent crude oil futures for April delivery decreased by $1.91 to $67.55 per barrel, down 2.75% [1] Economic News - The State Administration for Market Regulation announced new initiatives to optimize the "Two New" policy by 2026, focusing on enhancing traditional industries and promoting high-quality service sector development, including upgrading consumer goods standards to meet new consumer demands [2] - The Ministry of Industry and Information Technology released a plan for the high-quality development of the traditional Chinese medicine industry from 2026 to 2030, aiming to establish a collaborative development system and enhance the supply capacity of key raw materials [2] - A joint implementation opinion was issued to improve digital services for inbound travelers by 2027, aiming to enhance the internationalization and convenience of digital services in various sectors [3] - A notification was released regarding the "zero tariff" policy for imported goods purchased by residents of Hainan Free Trade Port, effective immediately, allowing for tax exemptions within specified limits [4] - In 2025, China's service trade is projected to grow steadily, with total service trade reaching 80823.1 billion yuan, a year-on-year increase of 7.4% [4] - The consumption of gold bars and coins in China surpassed that of gold jewelry for the first time in 2025, with total gold consumption at 950.096 tons, a decrease of 3.57% year-on-year [4] Company News - Meituan announced the acquisition of 100% of Dingdong Maicai's China business for approximately $717 million, with the overseas business excluded from the transaction [6] - NIO Inc. projected an adjusted operating profit of between 700 million and 1.2 billion yuan for Q4 2025, marking its first quarterly adjusted operating profit, compared to a loss of 5.5436 billion yuan in Q4 2024 [7]

Group 1 - The Ministry of Industry and Information Technology and eight other departments issued a plan for the high-quality development of the traditional Chinese medicine industry from 2026 to 2030, aiming to establish a collaborative development system across the entire industry chain by 2030 [1] - The plan includes enhancing the stable supply capacity of key traditional Chinese medicine raw materials, improving digital and green transformation levels, and achieving breakthroughs in key technologies [1] - The initiative aims to cultivate 60 high-standard traditional Chinese medicine raw material production bases and establish five innovation centers for the traditional Chinese medicine industry [1] Group 2 - The National Internet Information Office and 11 other departments released implementation opinions to enhance digital services for inbound personnel, targeting significant improvements in internationalization and convenience by 2027 [2] - By 2030, the goal is to achieve internationally leading levels in digital services for inbound personnel, with a mature ecosystem that connects digital services with international standards [2] - The implementation opinions outline 14 measures across five areas, including strengthening digital infrastructure, optimizing digital payment services, and enhancing digital public services [2] Group 3 - Amazon reported a revenue of $213.4 billion for Q4 2025, exceeding market expectations, but projected Q1 operating profit between $16.5 billion and $21.5 billion, below the anticipated $22.04 billion [5] - Following the earnings report, Amazon's stock dropped over 10% in after-hours trading [5] - The report also highlighted significant declines in commodity prices, with gold and silver experiencing notable drops [5] Group 4 - Meituan plans to acquire Dingdong for $717 million [6] - NIO forecasts an operating profit of 700 million to 1.2 billion yuan for Q4 2025 [6] - Guoxuan High-Tech intends to raise no more than 5 billion yuan for a 20GWh power battery project [6]

展望2026年， 国内中药材市场有望在政策引导、需求升级与产业转型的三重驱动下迎来好转。国家药 监局出台的《中药生产监督管理专门规定》将于2026年3月1日起正式实施，与此前已落地的《中药注册 管理专门规定》《中药标准管理专门规定》形成"三位一体"的监管闭环，进一步推动行业规范化、高质 量发展。 结构性分化将成为2026年中药材市场的核心特征。一方面，野生中药材资源枯竭的问题日益凸显，家种 品种价值攀升，北柴胡、关防风等品种供需缺口持续扩大，价格有望稳步上涨；另一方面，在健康消费 升级的背景下，药食同源品种需求呈现刚性增长态势，枸杞、黄芪等品种应用场景不断拓展，将带动原 料需求增加。 2月5日，工信部等八部门联合印发《中药工业高质量发展实施方案(2026—2030年)》，从全产业链视角 为中药工业未来五年发展划定"路线图"。《方案》围绕原料供应、创新能力、制造水平等维度设定量化 目标：到2030年培育60个高标准中药原料生产基地、建设5个中药工业守正创新中心、新培育10个中成 药大品种，推动一批医疗机构中药制剂转化为中药创新药，制修订10项中药工业数智技术相关行业标 准，发布20个数智化转型升级典型案例，建设 ...

智通财经APP获悉，2月5日，工信部等八部门联合印发《中药工业高质量发展实施方案(2026—2030 年)》，从全产业链视角为中药工业未来五年发展划定"路线图"。《方案》围绕原料供应、创新能力、 制造水平等维度设定量化目标：到2030年培育60个高标准中药原料生产基地、建设5个中药工业守正创 新中心、新培育10个中成药大品种，推动一批医疗机构中药制剂转化为中药创新药，制修订10项中药工 业数智技术相关行业标准，发布20个数智化转型升级典型案例，建设20个智能工厂、培育10个绿色工 厂。 《方案》还提到，在原料端，实施"提质稳供行动"，不仅要建设高标准生产基地，还将推广中药材趁鲜 切制工艺，解决产地初加工"小散乱"问题。创新环节，《方案》提出构建经典名方知识图谱、推动医疗 机构制剂转化，破解中药新药研发"周期长、成本高"的难题。在制造能力提升上，《方案》明确加快制 定全国中药饮片炮制规范、配方颗粒国家标准，同时推动智能工厂建设，实现从原料溯源到成品放行的 全流程数据监控。 光大证券医药表示，2026年中药行业的投资逻辑将从"成本修复"转向"价值成长"，政策红利的持续释放 与企业经营效率的提升，将推动行业盈利水平 ...

方案以稳定供应、协同创新、智能制造、产品推广、服务体系构建为抓手，统筹推进六个方面共15项任 务，包括加快制修订中药材生产加工关键环节生产技术规范和质量标准；运用人工智能、大数据等新一 代信息技术，构建经典名方、名老中医经验方等特色方剂知识图谱和图神经网络；加快制定实施全国中 药饮片炮制规范、配方颗粒国家标准，持续完善饮片质量标准体系。 此外，主要内容还包括整理特色炮制技术、方剂配伍和用药规范，建立完善质量控制体系；开发优势民 族药新产品，培育民族药名品；全方位推动中成药产品临床价值和市场价值双提升；加强中药工业国际 交流合作，鼓励开展优势中成药产品国际注册等。 方案明确，有关方面要将相关任务纳入制造业重点产业链高质量发展行动等工作体系，进一步完善国有 企业和政府引导基金考核和容错机制，鼓励其投资高标准中药原料生产基地建设、新药研发、医疗机构 中药制剂转化等长周期项目，加强中药制造能力提升和重大共性技术成果应用。 转自：贵州日报 新华社北京2月5日电 记者5日获悉，工业和信息化部等八部门日前联合印发《中药工业高质量发展实施 方案（2026—2030年）》，提出到2030年，中药工业全产业链协同发展体系初步形成 ...

2月5日，工业和信息化部等八部门印发《中药工业高质量发展实施方案（2026—2030年）》（以下简称 《实施方案》）。 《实施方案》提出了未来五年的发展目标：到2030年，中药工业全产业链协同发展体系初步形成，重点 中药原料持续稳定供应能力进一步增强，数智化、绿色化水平明显提升，一批关键技术取得突破，产业 协同创新水平显著提高。 设置四大目标 根据工业和信息化部消费品工业司披露的解读，《实施方案》着力推进产业政策、监管政策、医保政策 和临床使用政策的有效协同；充分发挥地方政府发展中药工业的积极性，鼓励各地因地制宜先行先试； 将原料的持续稳定供应作为产业链供应链稳定的"牛鼻子"；将支持中药工业龙头企业发展壮大、不断提 高行业集中度作为重中之重。 《实施方案》重点围绕发展质量、协同体系、创新产品、数智化绿色化转型升级等方面设置了具体的任 务目标。 四是数智化、绿色化转型升级取得突破，制修订10项中药工业数智技术相关行业标准，推动建设一批数 智化创新载体和公共服务平台，支持企业开展数智化改造提升，发布20个数智化转型升级典型案例，建 设20个智能工厂、培育10个绿色工厂。 围绕主要目标，《实施方案》聚焦原料提质稳供 ...